Morepen Laboratories Ltd

Desk›Healthcare› Morepen Laboratories Ltd

Morepen Laboratories Ltd

BSE 500288 · NSE MOREPENLAB · ISIN INE083A01026 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹96.62

-0.38%

BSE close, 28 August 2026

Market cap

₹5,294.33 cr

54.8 cr shares · Small cap

Free float

₹3,351.89 cr

as published

P/E · P/B

47.4× · 4.61×

EPS ₹2.04 · BV ₹20.96

FY25-26 rev / PAT

1,681.20 / 66.06

₹ cr, as filed

Filings, window

6 selected · 27%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

Against 52-week high	-3.1%
Against 52-week low	+188.9%
Day change	-0.38%
Size band	Small cap
Index membership	None

Valuation as published by BSE

Earnings per share	₹2.04
Price / earnings	47.36×
Price / book	4.61×
Book value — derived, price ÷ P/B	₹20.96
Return on equity	9.75%
Operating margin	15.69%
Net margin	9.98%

Consistency check

P/B ÷ P/E, which must equal ROE: 9.73%
ROE as published: 9.75%

Results ₹ crore, as filed

Jun-26 · Q

Mar-26 · Q

FY25-26

RevenueNet profit one scale across all three periods, ₹ crore

Period	Revenue ₹cr	Net profit ₹cr	EPS ₹	OPM	NPM
Jun-26 · Q	541.04	54.00	0.99	15.69%	9.98%
Mar-26 · Q	462.81	20.12	0.37	6.94%	4.35%
FY25-26	1,681.20	66.06	1.21	8.01%	3.93%

Quarter on quarter

Revenue, quarter on quarter: +16.9%
Net profit, quarter on quarter: +168.4%
Operating margin, quarter on quarter: +875 bps

Disclosure profile 22 filings in the window

Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Tag	Filings
Selected
Press Release	2
Board Outcome	1
Change in Management	1
Investor Presentation	1
Results	1
Selected sub-total	6
Procedural
General	5
Newspaper Publication	3
AGM / EGM	1
Annual Report	1
BRSR	1
Board Meeting	1
Monitoring Agency	1
Record Date	1
Subsidiary Incorporation	1
Trading Window	1
Procedural sub-total	16
Total	22

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

22 filings · 6 selected · busiest 2026-08-04

Filing rhythm · the twelve most recent

2026-08-052026-09-28

SelectedProcedural

Filings

22 in the window · 6 earlier on record

28 September 2026 · 16:40 IST

Trading Window

Closure of Trading Window

Closure of Trading Window for the quarter ended 30 September 2026

Insider Trading / SAST / Closure of Trading Window View filing →
28 September 2026 · 08:53 IST

Press Release

Press Release / Media Release (Revised)

Please find attached the press release

Company Update / Press Release / Media Release (Revised) View filing →
22 September 2026 · 16:10 IST

General

Intimation Regarding ESG Rating

Please find attached the file

Company Update / General View filing →
7 September 2026 · 08:53 IST

General

Announcement Under Regulation 30 Of The SEBI (LODR)

Business Update-First Phase of Manufacturing Capacity Expansion Completed Ahead of Schedule

Company Update / General View filing →
3 September 2026 · 12:51 IST

Newspaper Publication

Newspaper Publication

Newspaper publication for completion of dispatch of the notice of 41st AGM and Annual report for the FY 2025-26

Company Update / Newspaper Publication View filing →
2 September 2026 · 13:36 IST

General

Letter To The Members, (No E-Mail Id Registered), Comprising Weblink Of The Annual Report: 2025-26

Please find attached the specimen letter

Company Update / General View filing →
2 September 2026 · 13:28 IST

BRSR

Business Responsibility and Sustainability Reporting (BRSR)

Please find attached the BRSR for the financial year ended March 31, 2026

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
2 September 2026 · 13:23 IST

AGM / EGM

Notice Of 41St Annual General Meeting

Please find enclosed notice of 41st AGM scheduled to be held on Saturday 26th September 2026 at 1:00 p.m. through VC/OAVM.

AGM/EGM / AGM View filing →
2 September 2026 · 13:14 IST

Annual Report

Reg. 34 (1) Annual Report.

Please find attached the Annual Report for the financial year 2025-26 along with notice of 41st AGM

Others / Reg. 34 (1) Annual Report View filing →
26 August 2026 · 11:01 IST

Newspaper Publication

Newspaper Publication

Newspaper publication-information relating to 41st Annual General Meeting, Dividend and record date

Company Update / Newspaper Publication View filing →
6 August 2026 · 17:10 IST

Subsidiary Incorporation

Acquisition

Allotment of equity shares by Morepen RX Limited, wholly owned subsidiary of the company

Company Update / Acquisition View filing →
5 August 2026 · 12:30 IST

Newspaper Publication

Newspaper Publication

Newspaper Publication Financial Results for the quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
4 August 2026 · 15:46 IST

Monitoring Agency

Monitoring Agency Report

Please find attached the monitoring agency report for the quarter ended June 30, 2026

Company Update / Monitoring Agency Report View filing →
4 August 2026 · 14:33 IST

General

Intimation Of Annual General Meeting

41st Annual General Meeting scheduled to be held on September 26, 2026

Company Update / General View filing →
4 August 2026 · 14:23 IST

Change in Management

Change in Management

Re-appointment of Mr. Sushil Suri as Chairman & Managing Director w.e.f. October 20, 2026

Company Update / Change in Management View filing →
4 August 2026 · 14:17 IST

Record Date

Intimation Of Record Date For Payment Of Final Dividend I.E. September 19, 2026

Please find attached the file

Corp. Action / Record Date View filing →
4 August 2026 · 14:03 IST

Press Release

Press Release / Media Release

Please find attached the Press Release

Company Update / Press Release / Media Release View filing →
4 August 2026 · 13:58 IST

Investor Presentation

Investor Presentation

Please find attached the Q1 FY 27 Investor Presentation

Company Update / Investor Presentation View filing →
4 August 2026 · 13:46 IST

Board Outcome

Board Meeting Outcome for For Q1 FY 27 Financial Results

Please find attached the Q1 FY 27 Financial Results

Board Meeting / Outcome of Board Meeting View filing →
4 August 2026 · 13:43 IST

Results

Q1 FY 27 Financial Results

Please find attached the Q1 FY 27 Financial Results

Result / Financial Results View filing →
28 July 2026 · 17:06 IST

Board Meeting

Board Meeting Intimation for Q-1 FY27 Results

Morepen Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve financial results for ....

Board Meeting / Board Meeting View filing →
23 July 2026 · 18:45 IST

General

Intimation Of Name Change Of Wholly Owned Subsidiary Company

The name of wholly owned subsidiary company has been changed from Morepen Labs - FZCO to Morepen Labs FZE

Company Update / General View filing →

RSS feed for Morepen Laboratories Ltd · the 50 most recent filings

Price
Market cap
Sector
Index
PE
Latest quarter revenue
Net profit
Filings in the window